双层探测器光谱CT细胞外容积分数联合临床参数预测胃癌脉管及神经侵犯
回顾性纳入2023年9月至2025年2月124例胃癌患者,分为LVI/PNI阳性组85例与阴性组39例,行双层探测器光谱CT延迟期测量肿瘤碘浓度并计算ECV。ECV、CT-N分期及Borrmann分型为独立预测因子,联合模型训练组AUC 0.920、验证组0.917,优于CT-N分期模型和Borrmann分型模型,但较ECV单参数模型提升无统计学意义。
要点
- 延迟期双层探测器光谱CT可计算ECV,公式为ECV=(1-血细胞比容)×(肿瘤碘浓度/同层面腹主动脉碘浓度)。
- ECV、CT-N分期、Borrmann分型是胃癌LVI/PNI复合终点的独立预测因子(均P<0.05)。
- 联合模型训练组AUC 0.920、验证组0.917,对CT-N分期模型和Borrmann分型模型的提升有统计学意义,对ECV单参数模型提升无统计学意义。
核心结论
- 延迟期双层探测器光谱CT衍生的ECV有望作为无创生物标志物识别胃癌LVI/PNI复合终点,联合ECV、CT-N分期和Borrmann分型的模型整体诊断性能最佳,但较ECV单参数的增量获益似乎有限。
研究设计与样本
- 回顾性研究,纳入本院2023年9月至2025年2月124例胃癌患者,按术后组织病理分为LVI/PNI阳性组85例与阴性组39例,均行增强双层探测器光谱CT,以术后病理为参考标准。
关键影像表现/征象
- 于延迟期测量肿瘤内碘浓度及同解剖层面腹主动脉碘浓度,结合术前血细胞比容计算ECV;未报告其他影像征象。
诊断标准与关键数值
- 以术后组织病理LVI/PNI结果为参考,联合模型(ECV+CT-N分期+Borrmann分型)预测LVI/PNI复合终点的AUC训练组0.920、验证组0.917;DeLong分析显示联合模型在两个队列中均显著优于CT-N分期模型和Borrmann分型模型,但较ECV单参数模型的提升无统计学意义。
临床应用与阅片要点
- 作者认为延迟期双层探测器光谱CT衍生ECV是有前景的无创生物标志物,联合模型(ECV、CT-N分期、Borrmann分型)整体诊断性能最佳,但较ECV单参数的增量获益似乎有限。
局限性
- 原文为回顾性研究。
- 原文结论指出联合模型较ECV单参数的增量获益似乎有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to evaluate the feasibility and diagnostic performance of extracellular volume fraction (ECV), derived from iodine concentration (IC) values obtained through dual-layer detector spectral CT, in combination with clinical parameters, for preoperative prediction of lymphovascular invasion and/or perineural invasion (LVI/PNI) in gastric cancer.
METHODS: This retrospective study included clinical and pathologic data of 124 patients diagnosed with GC at our hospital between September 2023 and February 2025. The patients were stratified into LVI/PNI-positive (n = 85) and LVI/PNI-negative (n = 39) groups based on their postoperative histopathologic findings. All patients underwent contrast-enhanced dual-layer detector spectral CT. Preoperative hematocrit levels were obtained, and IC values within the tumor were measured during the delayed phase. Concurrently, IC in the abdominal aorta at the same anatomical level was measured to calculate the ECV using the formula: ECV = (1 - hematocrit) × (IC_tumor / IC_blood). Clinical variables and spectral CT parameters were analyzed using univariate analysis, LASSO selection, and multivariable logistic regression to identify independent predictors of the composite LVI/PNI endpoint. The diagnostic performance of individual parameters and the combined model for preoperatively predicting vascular and neural invasion was assessed using receiver operating characteristic (ROC) curve analysis.
RESULTS: ECV, CT-N stage, and Borrmann classification were identified as independent predictors of the composite LVI/PNI endpoint in patients with GC (all P < 0.05). Among the candidate models, the combined model incorporating ECV, CT-N stage, and Borrmann classification achieved the best predictive performance, with AUCs of 0.920 in the training cohort and 0.917 in the validation cohort. DeLong analysis showed that the combined model significantly outperformed the CT-N stage model and the Borrmann classification model in both cohorts. However, its improvement over the ECV-only model was not statistically significant.
CONCLUSIONS: Delayed-phase dual-layer detector spectral CT-derived ECV is a promising noninvasive biomarker for identifying the composite LVI/PNI endpoint in gastric cancer. A combined model integrating ECV, CT-N stage, and Borrmann classification provides the best overall diagnostic performance, although its incremental benefit over ECV alone appears limited.
引用
- Guo R, Chang K, Yan Q, et al. Dual-layer detector spectral CT-derived extracellular volume fraction combined with clinical parameters for predicting lymphovascular and perineural invasion in gastric cancer. Abdom Radiol (NY). 2026. PMID: 41893908. doi:10.1007/s00261-026-05475-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。